NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,286 | -$82,954 | -$26,754 | -$23,265 |
| Dep. & Amort. | $1,315 | $1,203 | $1,650 | $1,244 |
| Deferred Tax | $0 | -$6,512 | $177 | $143 |
| Stock-Based Comp. | $4,142 | $4,135 | $69 | $93 |
| Change in WC | $0 | $2,226 | $30 | $932 |
| Other Non-Cash | $17,948 | $59,954 | $2,271 | $1,305 |
| Operating Cash Flow | -$20,881 | -$21,948 | -$22,557 | -$19,548 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$48 | -$163 | -$459 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$171,615 |
| Inv. Sales/Matur. | $0 | $0 | $569 | $0 |
| Other Inv. Act. | -$13 | $0 | -$569 | $171,615 |
| Investing Cash Flow | -$13 | -$48 | -$163 | -$459 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $26,206 | $22,325 | $20,096 |
| Stock Issued | $100 | $1,668 | $161 | $63 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $20,853 | -$5,719 | $161 | $0 |
| Financing Cash Flow | $20,853 | $22,155 | $22,486 | $20,159 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,699 | $159 | -$234 | $152 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $276 | $117 | $351 | $199 |
| End Cash | $1,975 | $276 | $117 | $351 |
| Free Cash Flow | -$20,881 | -$21,996 | -$22,720 | -$20,007 |